Clinical-Therapeutic Importance of Bioimpedance in Patients with Lymphedema: A Systematic Review

Immunome research Pub Date : 2019-01-01 DOI:10.35248/1745-7580.19.15.167

Annelise de Assis Silva, Maria Antonia Morais de MeloAna Julia Salim Casseb, Maria Eduarda RosaTeles, Victoria Rodrigues Teixeira de Oliveira, J. M. Godoy, Fern, o Batigalia, I. Filho, R. Ramos

{"title":"Clinical-Therapeutic Importance of Bioimpedance in Patients with Lymphedema: A Systematic Review","authors":"Annelise de Assis Silva, Maria Antonia Morais de MeloAna Julia Salim Casseb, Maria Eduarda RosaTeles, Victoria Rodrigues Teixeira de Oliveira, J. M. Godoy, Fern, o Batigalia, I. Filho, R. Ramos","doi":"10.35248/1745-7580.19.15.167","DOIUrl":null,"url":null,"abstract":"Introduction: Lymphedema is characterized by abnormal accumulation of macromolecules and soft tissue fluids. Bioimpedance is a method that measures intra- and extracellular volumes by body segment, and has been currently used in lymphedema. Objective: The objective of this study was to conduct a systematic review of the clinical-therapeutic importance of bioimpedance in patients with lymphedema. Methodology: The present work consisted of a literature review. The systematic review made it possible to know and transcribe important subjects on clinical and therapeutic bioimpedance in patients with lymphedema. The work was carried out from September 2018 to April 2019, following the rules of systematic review – PRISMA. Results: It was found that the variation of the interstitial fluid can be measured by bioimpedance , before and after intensive treatment of lymphedema. Bioimpedance is a noninvasive method used to evaluate interstitial fluids, including indications for lymphedema. Conclusion: Bioimpedance is a suggested method to evaluate clinical and therapeutic follow-up in patients with lymphedema.","PeriodicalId":73347,"journal":{"name":"Immunome research","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunome research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/1745-7580.19.15.167","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

Abstract

Introduction: Lymphedema is characterized by abnormal accumulation of macromolecules and soft tissue fluids. Bioimpedance is a method that measures intra- and extracellular volumes by body segment, and has been currently used in lymphedema. Objective: The objective of this study was to conduct a systematic review of the clinical-therapeutic importance of bioimpedance in patients with lymphedema. Methodology: The present work consisted of a literature review. The systematic review made it possible to know and transcribe important subjects on clinical and therapeutic bioimpedance in patients with lymphedema. The work was carried out from September 2018 to April 2019, following the rules of systematic review – PRISMA. Results: It was found that the variation of the interstitial fluid can be measured by bioimpedance , before and after intensive treatment of lymphedema. Bioimpedance is a noninvasive method used to evaluate interstitial fluids, including indications for lymphedema. Conclusion: Bioimpedance is a suggested method to evaluate clinical and therapeutic follow-up in patients with lymphedema.

查看原文本刊更多论文

生物阻抗在淋巴水肿患者临床治疗中的重要性:一项系统综述

简介:淋巴水肿的特征是大分子和软组织液体的异常积聚。生物阻抗是一种通过身体部分测量细胞内和细胞外体积的方法，目前已用于淋巴水肿。目的:本研究的目的是对生物阻抗在淋巴水肿患者的临床治疗重要性进行系统回顾。方法:本研究包括文献综述。系统评价使得了解和记录淋巴水肿患者临床和治疗生物阻抗的重要课题成为可能。这项工作于2018年9月至2019年4月进行，遵循系统审查- PRISMA的规则。结果:采用生物阻抗法测定淋巴水肿强化治疗前后间质液的变化。生物阻抗是一种用于评估间质液的无创方法，包括淋巴水肿的适应症。结论:生物阻抗是评价淋巴水肿患者临床和治疗随访的一种理想方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Immunome research

自引率

0.00%

发文量